Get started
Author

Christophe Blanquart

Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
2001 · Geneviève Martin, Hélène Duez, et al. · Journal of Clinical Investigation · 419
PDF
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
2002 · O. Barbier, I. Pineda Torra, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 418
Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation
2003 · Christophe Blanquart, Olivier Barbier, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 315
FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity
2003 · Olivier Barbier, Ines Pineda Torra, et al. · Gastroenterology · 215
Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator–Activated Receptor-α via Inhibition of the Protein Kinase C Signaling Pathway
2006 · Réjane Paumelle, Christophe Blanquart, et al. · Circulation Research · 165
Peroxisome Proliferator-activated Receptor α (PPARα) Turnover by the Ubiquitin-Proteasome System Controls the Ligand-induced Expression Level of Its Target Genes
2002 · Christophe Blanquart, Olivier Barbier, et al. · Journal of Biological Chemistry · 156
PDF
Human Lactoferrin Interacts with Soluble CD14 and Inhibits Expression of Endothelial Adhesion Molecules, E-Selectin and ICAM-1, Induced by the CD14-Lipopolysaccharide Complex
2000 · S. Baveye, E. Elass, et al. · Infection and Immunity · 150
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
2021 · Tina Briolay, Tacien Petithomme, et al. · Molecular Cancer · 143
PDF
Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma
2011 · Fabien Gueugnon, Sabrina Leclercq, et al. · American Journal Of Pathology · 121
PDF
The Protein Kinase C Signaling Pathway Regulates a Molecular Switch between Transactivation and Transrepression Activity of the Peroxisome Proliferator-Activated Receptor α
2004 · Christophe Blanquart, Roxane Mansouri, et al. · Molecular Endocrinology · 107
PDF
Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
2016 · Anne-Laure Chéné, Sènan d’Almeida, et al. · Journal of Thoracic Oncology · 93
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
2020 · Vanessa Gauttier, Sabrina Pengam, et al. · Journal of Clinical Investigation · 84
PDF
Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities
2021 · Margot Lavy, Vanessa Gauttier, et al. · Frontiers in Immunology · 75
PDF
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus
2020 · Tiphaine Delaunay, Carole Achard, et al. · Journal of Thoracic Oncology · 69
PDF
Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer
2008 · Christophe Blanquart, Josepha Achi, et al. · Biochemical Pharmacology · 64
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
2020 · Thibaut Blondy, Sènan Mickael d'Almeida, et al. · Journal for ImmunoTherapy of Cancer · 60
PDF
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
2019 · Pierre Autin, Christophe Blanquart, et al. · Cancers · 58
PDF
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
2018 · Douae Bensaid, Thibaut Blondy, et al. · Clinical Epigenetics · 53
PDF
HDAC1‐mSin3a‐NCOR1, Dnmt3b‐HDAC1‐Egr1 and Dnmt1‐PCNA‐UHRF1‐G9a regulate the NY‐ESO1 gene expression
2012 · Pierre-François Cartron, Christophe Blanquart, et al. · Molecular Oncology · 50
PDF
Interaction with Grb14 results in site‐specific regulation of tyrosine phosphorylation of the insulin receptor
2006 · Sébastien Nouaille, Christophe Blanquart, et al. · EMBO Reports · 50
The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
2020 · Christophe Blanquart, Marie-Claude Jaurand, et al. · Frontiers in Oncology · 46
PDF
CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions
2012 · Christophe Blanquart, Fabien Gueugnon, et al. · Journal of Thoracic Oncology · 45
Nanoparticles Produced by Ring-Opening Metathesis Polymerization Using Norbornenyl-poly(ethylene oxide) as a Ligand-Free Generic Platform for Highly Selective In Vivo Tumor Targeting
2013 · Fabien Gueugnon, Iza Denis, et al. · Biomacromolecules · 44
Vorinostat–Polymer Conjugate Nanoparticles for Acid-Responsive Delivery and Passive Tumor Targeting
2014 · Iza Denis, Fatima el Bahhaj, et al. · Biomacromolecules · 42
A 5-aza-2′-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma
2011 · S. Leclercq, F. Gueugnon, et al. · European Respiratory Journal · 42
PDF
Works count: 202
Citation count: 4,108
H-index: 30
I10-index: 65
Year
Topic
Type